Comprehensive Investment Portfolio Composition as of June 30, 2021
Comprehensive Investment Portfolio Composition
(at fair value) |
Amount ($mm) |
Amount % |
Weighted Average
Asset-level Yield(5) |
| |
|
|
|
| Cash Flow Senior Secured Loans |
$338.6 |
17.6% |
8.4% |
| Asset-Based Senior Secured Loans / Crystal Financial(1) |
$389.8 |
20.3% |
10.3% |
| Equipment Senior Secured Financings / NEF(2) |
$313.8 |
16.4% |
9.9% |
| Life Science Senior Secured Loans |
$270.7 |
14.1% |
9.7%(6) |
| Corporate Leasing / KBH(3) |
$592.2 |
30.9% |
10.2(7) |
| Total Senior Secured Loans |
$1,905.1 |
99.3% |
9.8% |
| Equity and Equity-like Securities |
$13.6 |
0.7% |
|
| Total Comprehensive Investment Portfolio |
$1,918.7 |
100% |
|
| Floating Rate Investments(4) |
$1,002.4 |
52.5% |
|
| First Lien Senior Secured Loans |
$1,821.9 |
95.0% |
|
| Second Lien Senior Secured Cash Flow Loans |
$46.8 |
2.4% |
|
| Second Lien Senior Secured Asset-based Loans |
$36.4 |
1.9% |
|
1 Includes SLR Credit Solution's ("SLR-CS") full portfolio and asset-based loans and lender finance loans on the Company’s balance sheet and excludes the Company's equity investment in SLR-CS.
2 Includes SLR Equipment Finance's ("SLR-EF") full portfolio and SLR-EF equipment financings on the Company’s balance sheet and excludes the Company's equity investment in SLR-EF.
3 Includes KBH's full portfolio and excludes the Company's equity and debt investments in KBH.
4 Floating rate investments calculated as a percent of the Company’s income-producing Comprehensive Investment Portfolio. The majority of fixed rate loans are associated with SLR-EF and leases associated with KBH. Additionally, SLR-EF and KBH seeks to match-fund their fixed rate assets with fixed rate liabilities.
5 Represents the weighted average yield for cash flow, asset-based and life science loans on balance sheet is based on a yield to maturity calculation. The weighted average yield for equipment financing and SLR-CS asset-based loans is calculated based on the expected average life of a loan for each asset class.
6 Life science yields exclude the impact of success fees and/or warrants.
7 Represents the annualized Q2 2021 dividend yield at cost on SLRC’s equity investment in KBH.